GILD vs HWKN · P/E 18, rev $7.80B vs P/E 40, rev $1.08B
Gilead Sciences Inc (GILD) versus Hawkins Inc (HWKN) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Hawkins Inc (HWKN) is a specialty chemicals company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported HWKN revenue for 2026-03-29 was $1.08B. Net income was $81.5M. Revenue was up 11.2% from 2025-03-30 to 2026-03-29. HWKN currently screens at market cap $3.24B and trailing P/E 39.7.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. HWKN currently screens at market cap $3.24B and trailing P/E 39.7.
Not investment advice. Open the GILD and HWKN stock pages for the full models.
Not investment advice.